Sign In  |  Register  |  About Livermore  |  Contact Us

Livermore, CA
September 01, 2020 1:25pm
7-Day Forecast | Traffic
  • Search Hotels in Livermore

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Modivcare Reports Second Quarter 2023 Financial Results and Adjusts 2023 Guidance

Modivcare Inc., (the “Company” or “Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions addressing the social determinants of health and improving health outcomes, today reported financial results for the three and six months ended June 30, 2023.

Second Quarter 2023 Highlights:

  • Service revenue of $699.1 million, an 11.3% increase as compared to $628.2 million in the second quarter of 2022
  • Net loss of $190.9 million or $13.47 per diluted common share, primarily attributable to goodwill impairment of $183.1 million
  • Adjusted EBITDA(1) of $52.4 million, adjusted net income(1) of $20.8 million and adjusted EPS(1) of $1.47 per diluted common share
  • Cash used in operating activities during the quarter of $108.2 million along with capex spend of $8.9 million
  • Contract payables decreased by $78.5 million to $109.1 million and contract receivables increased by $17.4 million to $119.8 million, resulting in net contract receivables of $10.7 million as of June 30, 2023
  • $126.5 million drawn on the $325.0 million revolving credit facility as of June 30, 2023
  • Amended credit agreement’s maximum Total Net Leverage Ratio to provide improved access to liquidity

 

 

(1) Non-GAAP financial measure reconciliations and other related information about non-GAAP financial measures provided below

"Modivcare continues to transform into a more efficient tech-enabled platform with a differentiated offering in the health care services market. Revenue growth of 11% during the second quarter of 2023 was driven by strong growth across our Home and Mobility businesses,” stated L. Heath Sampson, President, and CEO. “Our Home division is benefiting from our centralization and standardization initiatives, which helped drive double-digit revenue and Adjusted EBITDA growth. We made significant progress on our move towards One Modivcare during the second quarter by accelerating the creation of a longitudinal member profile that will allow us to improve member experience, lower costs, and generate proactive outcome-based insights. Membership in our Mobility division increased 2% sequentially driven by expansions of existing contracts, with 5% Medicare Advantage growth and 1% Medicaid member growth, despite the initial impact of Medicaid redeterminations. However, in the near-term, increased utilization and related higher call volumes in NEMT, along with new contract win implementation delays, and contract attrition from prior years, prompted us to revise our 2023 full-year Adjusted EBITDA guidance to an updated range of $200 million to $210 million. Our cash flow was also negatively impacted during the second quarter of 2023 due to a $96 million decline in our contract payables, net of receivables. We expect positive cash flow in the second half of the year, as collections on our contract receivables align with or exceed declines on our contract payables. Despite the near-term challenges, we believe our business is well positioned to generate strong long-term performance as we continue to drive us towards our unique One Modivcare vision."

2023 Guidance

We updated our revenue and adjusted EBITDA guidance ranges as follows ($ in millions):

 

Updated

 

Previous

 

Low

 

High

 

Low

 

High

Revenue

$

2,750

 

$

2,800

 

$

2,575

 

$

2,600

Adjusted EBITDA

$

200

 

$

210

 

$

225

 

$

235

Guidance excludes the effects of any future merger or acquisition activity and is based on the current operating environment.

Second Quarter 2023 Results

For the second quarter of 2023, the Company reported revenue of $699.1 million, an increase of 11.3% from $628.2 million in the second quarter of 2022. The increase in revenue is primarily attributable to a 1.5% increase in membership and an 9.0% increase in revenue per member per month in our NEMT segment coupled with a 3.4% increase in hours worked and a 7.2% increase in rate per hour in our Personal Care segment.

Our operating loss was $175.8 million, or 25.1% of revenue, in the second quarter of 2023, compared to operating income of $23.1 million, or 3.7% of revenue, in the second quarter of 2022. Net loss in the second quarter of 2023 was $190.9 million, or $13.47 per diluted common share, compared to net income of $3.3 million, or $0.24 per diluted common share, in the second quarter of 2022. Both the operating loss and the net loss for the second quarter of 2023 are primarily attributable to the non-cash goodwill impairment of $183.1 million.

Adjusted EBITDA was $52.4 million, or 7.5% of revenue, in the second quarter of 2023, compared to $60.2 million, or 9.6% of revenue, in the second quarter of 2022. Our Adjusted EBITDA decreased primarily as a result of a $17.5 million decrease in the NEMT segment. This decrease was driven by increased service expense per trip and higher than expected trip volume, as well as contract losses that impacted NEMT's operating margin. Accordingly, adjusted net income in the second quarter of 2023 was $20.8 million, or $1.47 per diluted common share, compared to $28.1 million, or $1.99 per diluted common share, in the second quarter of 2022.

Cash used in operations during the quarter was $108.2 million as compared to $17.9 million during the second quarter of 2022. The primary use of cash during the quarter was a net $78.5 million reduction in contract payables, coupled with a $17.4 million increase in contract receivables, for a total use of cash of $95.9 million. As of the quarter end, we are in a net contract receivables position of $10.7 million.

During the second quarter, a goodwill impairment of $183.1 million was recognized, as the Company performed its annual goodwill impairment assessment and determined that based on its qualitative assessment for each reporting unit, factors existed which required the Company to perform a quantitative assessment to test its goodwill for impairment. These factors included a decline in the market price of the Company's common stock and general economic and market volatility.

Second Quarter Earnings Conference Call

Modivcare will hold a conference call to discuss its financial results on Friday, August 4, 2023 at 8:30 a.m. ET. To access the call, please dial:

US toll-free: 1 (877) 407-8037

International: 1 (201) 689-8037

You may also access the conference call via webcast at investors.modivcare.com, where the call will also be archived.

About Modivcare

Modivcare Inc. (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their patients. Our value-based solutions are intended to address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal care and remote patient monitoring. To learn more about Modivcare, please visit www.modivcare.com.

Non-GAAP Financial Measures and Adjustments

In addition to the financial measures prepared in accordance with generally accepted accounting principles in the United States ("GAAP"), this press release includes (as applicable) EBITDA, Adjusted EBITDA and Adjusted G&A expense for the Company and its segments, Adjusted EBITDA margin for the Company's segments (other than its Corporate segment), and Adjusted Net Income and Adjusted EPS for the Company, all of which are performance measures that are not recognized under GAAP. EBITDA is defined as net income (loss) before: (1) interest expense, net, (2) provision (benefit) for income taxes, and (3) depreciation and amortization. Adjusted EBITDA is calculated as EBITDA before (as applicable): (1) restructuring and related costs, (2) transaction and integration costs, (3) settlement related costs, (4) cash settled equity, (5) stock-based compensation, (6) impairment of goodwill, (7) COVID-19 related costs, net of grant income, and (8) equity in net (income) loss of investee, net of tax. Adjusted EBITDA margin is calculated as Adjusted EBITDA, divided by service revenue, net. Adjusted Net Income is calculated as net income (loss) before: (1) restructuring and related costs, (2) transaction and integration costs, (3) settlement related costs, (4) cash settled equity, (5) stock-based compensation, (6) impairment of goodwill, (7) equity in net (income) loss of investee, net of tax (8) intangible asset amortization expense, (9) COVID-19 related costs, net of grant income, and (10) the income tax impact of such adjustments. Adjusted EPS is calculated as Adjusted Net Income divided by the diluted weighted-average number of common shares outstanding as calculated for Adjusted Net Income. Adjusted G&A expense is calculated as G&A expense before (as applicable): (1) restructuring and related costs, (2) transaction and integration costs, (3) settlement related costs, (4) cash settled equity, and (5) stock-based compensation. Reconciliations of the non-GAAP financial measures to their most directly comparable GAAP financial measures are included below. We do not provide guidance for net income (loss) in this presentation on a basis consistent with GAAP or a reconciliation of forward-looking non-GAAP financial measures to their most directly comparable GAAP financial measures on a forward-looking basis because we are unable to predict items contained in the GAAP financial measures without unreasonable efforts. Our non-GAAP performance measures exclude expenses and amounts that are not driven by our core operating results and may be one time in nature. Excluding these expenses makes comparisons with prior periods as well as to other companies in our industry more meaningful. We believe such measures allow investors to gain a better understanding of the factors and trends affecting the ongoing operations of our business. We consider our core operations to be the ongoing activities to provide services from which we earn revenue, including direct operating costs and indirect costs to support these activities. As a result, our net income or loss in equity investee is excluded from these measures, as we do not have the ability to manage the venture, allocate resources within the venture, or directly control its operations or performance.

Our non-GAAP financial measures may not provide information that is directly comparable to that provided by other companies in our industry, as other companies in our industry may calculate non-GAAP financial measures differently. In addition, there are limitations in using non-GAAP financial measures because they are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and exclude expenses that may have a material impact on our reported financial results. The presentation of non-GAAP financial measures is not intended to be considered in isolation from or as a substitute for the most directly comparable financial measures prepared in accordance with GAAP. We urge you to review the reconciliations of our non-GAAP financial measures to the most directly comparable GAAP financial measures included below, and not to rely on any single financial measure to evaluate our business.

Forward-Looking Statements

Certain statements contained in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are predictive in nature and are frequently identified by the use of terms such as “may,” “will,” “should,” “expect,” “believe,” “estimate,” “intend,” and similar words indicating possible future expectations, events or actions. The updated guidance discussed herein constitutes forward-looking statements. Such forward-looking statements are based on current expectations, assumptions, estimates and projections about our business and our industry, and are not guarantees of our future performance. These statements are subject to a number of known and unknown risks, uncertainties and other factors, many of which are beyond our ability to control or predict, which may cause actual results to be materially different from those expressed or implied herein, including but not limited to: government or private insurance program funding reductions or limitations; implementation of alternative payment models or the transition of Medicaid and Medicare beneficiaries to Managed Care Organizations; our inability to control reimbursement rates received for our services; cost containment initiatives undertaken by private third-party payors and an inability to maintain or reduce our cost of services below rates set forth by our payors; the effects of a public health emergency; inadequacies in our information technology systems; changes in the funding, financial viability or our relationships with our payors; pandemics and other infectious diseases; disruptions to our contact center operations caused by health epidemics or pandemics; delays in collection of our accounts receivable; any impairment of our goodwill and long-lived assets; any failure to maintain or to develop reliable, efficient and secure information technology systems; any inability to attract and retain qualified employees; any disruptions from acquisition or acquisition integration efforts; estimated income taxes being different from income taxes that we ultimately pay; our contracts not surviving until the end of their stated terms, or not being renewed or extended; our failure to compete effectively in the marketplace; our not being awarded contracts through the government’s requests for proposals process, or our awarded contracts not being profitable; any failure to satisfy our contractual obligations or to maintain existing pledged performance and payment bonds; any failure to estimate accurately the cost of performing our contracts; any misclassification of the drivers we engage as independent contractors rather than as employees; significant interruptions in our communication and data services; not successfully executing on our strategies in the face of our competition; any inability to maintain relationships with existing patient referral sources; certificates of need laws or other regulatory and licensure obligations that may adversely affect our personal care integration efforts and expansion into new markets; any failure to obtain the consent of the New York Department of Health to manage the day to day operations of our licensed in-home personal care services agency business; changes in the case-mix of our personal care patients, or changes in payor mix or payment methodologies; our loss of existing favorable managed care contracts; our experiencing labor shortages in qualified employees and management; labor disputes or disruptions, in particular in New York; becoming subject to malpractice or other similar claims; our operating in the competitive remote patient monitoring industry, and failing to develop and enhance related technology applications; any failure to innovate and provide services that are useful to customers and to achieve and maintain market acceptance; our lack of sole decision-making authority with respect to our minority investment in Matrix and any failure by Matrix to achieve positive financial position and results of operations; the cost of our compliance with laws; changes to the regulatory landscape applicable to our businesses; changes in budgetary priorities of the government entities or private insurance programs that fund our services; regulations relating to privacy and security of patient and service user information; actions for false claims or recoupment of funds; civil penalties or loss of business for failing to comply with bribery, corruption and other regulations governing business with public organizations; changes to, or violations of, licensing regulations; our contracts being subject to audit and modification by the payors with whom we contract; a loss of Medicaid coverage by a significant number of Medicaid beneficiaries following the expiration of the COVID-19 public health emergency under the Families First Coronavirus Response Act (2020); our existing debt agreements containing restrictions that limit our flexibility in operating our business; our substantial indebtedness and lease obligations; any loss of available financing alternatives; our ability to incur substantial additional indebtedness; and the results of the remediation of our identified material weaknesses in internal control over financial reporting.

The Company has provided additional information about the risks facing our business in our annual report on Form 10-K and subsequent periodic and current reports most recently filed with the Securities and Exchange Commission that could impact future performance. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date the statement was made and are expressly qualified in their entirety by the cautionary statements set forth herein and in our filings with the Securities and Exchange Commission, which you should read in their entirety before making an investment decision with respect to our securities. We undertake no obligation to update or revise any forward-looking statements contained in this release, whether as a result of new information, future events or otherwise, except as required by applicable law.

Modivcare Inc.

Unaudited Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

 

 

 

 

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

 

Service revenue, net

 

$

699,107

 

 

$

628,215

 

 

$

1,361,413

 

 

$

1,202,690

 

Grant income

 

 

2,634

 

 

 

3,330

 

 

 

4,098

 

 

 

3,798

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

Service expense

 

 

589,255

 

 

 

504,230

 

 

 

1,139,521

 

 

 

963,545

 

General and administrative expense

 

 

79,240

 

 

 

79,411

 

 

 

158,953

 

 

 

156,219

 

Depreciation and amortization

 

 

25,909

 

 

 

24,758

 

 

 

51,602

 

 

 

48,704

 

Impairment of goodwill

 

 

183,100

 

 

 

 

 

 

183,100

 

 

 

 

Total operating expenses

 

 

877,504

 

 

 

608,399

 

 

 

1,533,176

 

 

 

1,168,468

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

(175,763

)

 

 

23,146

 

 

 

(167,665

)

 

 

38,020

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

16,967

 

 

 

15,472

 

 

 

32,925

 

 

 

30,872

 

Income (loss) before income taxes and equity method investment

 

 

(192,730

)

 

 

7,674

 

 

 

(200,590

)

 

 

7,148

 

Income tax (provision) benefit

 

 

830

 

 

 

(2,291

)

 

 

2,703

 

 

 

(1,930

)

Equity in net income (loss) of investee, net of tax

 

 

956

 

 

 

(2,055

)

 

 

2,981

 

 

 

(1,572

)

Net income (loss)

 

$

(190,944

)

 

$

3,328

 

 

$

(194,906

)

 

$

3,646

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per common share:

 

 

 

 

 

 

 

 

Basic

 

$

(13.47

)

 

$

0.24

 

 

$

(13.76

)

 

$

0.26

 

Diluted

 

$

(13.47

)

 

$

0.24

 

 

$

(13.76

)

 

$

0.26

 

 

 

 

 

 

 

 

 

 

Weighted-average number of common shares outstanding:

 

 

 

 

 

 

Basic

 

 

14,170,617

 

 

 

14,047,459

 

 

 

14,162,776

 

 

 

14,035,588

 

Diluted

 

 

14,170,617

 

 

 

14,115,471

 

 

 

14,162,776

 

 

 

14,122,730

 

Modivcare Inc.

Unaudited Condensed Consolidated Balance Sheets

(in thousands)

 

 

 

 

 

 

 

June 30, 2023

 

December 31, 2022

Assets

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

6,898

 

$

14,451

Accounts receivable, net

 

 

224,013

 

 

223,210

Contract receivables

 

 

119,763

 

 

71,131

Other current assets(1)

 

 

42,275

 

 

37,362

Total current assets

 

 

392,949

 

 

346,154

Property and equipment, net

 

 

78,922

 

 

69,138

Goodwill

 

 

785,554

 

 

968,654

Intangible assets, net

 

 

400,287

 

 

439,409

Equity investment

 

 

45,114

 

 

41,303

Operating lease right-of-use assets

 

 

39,301

 

 

39,405

Other long-term assets

 

 

42,893

 

 

40,209

Total assets

 

$

1,785,020

 

$

1,944,272

 

 

 

 

 

Liabilities and stockholders' equity

 

 

 

 

Current liabilities:

 

 

 

 

Short-term borrowings

 

$

126,500

 

$

Accounts payable

 

 

56,047

 

 

54,959

Accrued contract payables

 

 

109,094

 

 

194,287

Accrued expenses and other current liabilities

 

 

138,178

 

 

135,860

Accrued transportation costs

 

 

94,118

 

 

96,851

Current portion of operating lease liabilities

 

 

9,298

 

 

9,640

Total current liabilities

 

 

533,235

 

 

491,597

Long-term debt, net of deferred financing costs

 

 

981,526

 

 

979,361

Operating lease liabilities, less current portion

 

 

32,396

 

 

32,088

Other long-term liabilities(2)

 

 

76,422

 

 

86,670

Total liabilities

 

 

1,623,579

 

 

1,589,716

 

 

 

 

 

Stockholders' equity

 

 

 

 

Stockholders' equity

 

 

161,441

 

 

354,556

Total liabilities and stockholders' equity

 

$

1,785,020

 

$

1,944,272

(1)

Includes other receivables, prepaid expenses and other current assets and short-term restricted cash.

(2)

Includes other long-term liabilities and deferred tax liabilities.

Modivcare Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

(in thousands)

 

 

 

 

 

 

 

Six months ended June 30,

 

 

2023

 

2022

Operating activities

 

 

 

 

Net income (loss)

 

$

(194,906

)

 

$

3,646

 

Depreciation and amortization

 

 

51,602

 

 

 

48,704

 

Stock-based compensation

 

 

2,286

 

 

 

4,496

 

Equity in net (income) loss of investee

 

 

(4,137

)

 

 

2,358

 

Deferred income taxes

 

 

(10,264

)

 

 

(14,493

)

Impairment of goodwill

 

 

183,100

 

 

 

 

Reduction of right-of-use asset

 

 

6,951

 

 

 

5,757

 

Other non-cash items(1)

 

 

(108

)

 

 

(6,495

)

Changes in working capital(2)

 

 

(145,398

)

 

 

7,233

 

Net cash provided by (used in) operating activities

 

 

(110,874

)

 

 

51,206

 

 

 

 

 

 

Investing activities

 

 

 

 

Purchase of property and equipment

 

 

(22,265

)

 

 

(15,899

)

Acquisitions, net of cash acquired

 

 

 

 

 

(78,861

)

Net cash used in investing activities

 

 

(22,265

)

 

 

(94,760

)

 

 

 

 

 

Financing activities

 

 

 

 

Proceeds from short-term borrowings

 

 

126,500

 

 

 

 

Debt issuance costs

 

 

(376

)

 

 

(2,415

)

Proceeds from common stock issued pursuant to stock option exercise

 

 

31

 

 

 

1,138

 

Restricted stock surrendered for employee tax payment

 

 

(840

)

 

 

(607

)

Other financing activities

 

 

315

 

 

 

 

Net cash provided by (used in) financing activities

 

 

125,630

 

 

 

(1,884

)

 

 

 

 

 

Net change in cash, cash equivalents and restricted cash

 

 

(7,509

)

 

 

(45,438

)

Cash, cash equivalents and restricted cash at beginning of period

 

 

14,975

 

 

 

133,422

 

Cash, cash equivalents and restricted cash at end of period

 

$

7,466

 

 

$

87,984

 

(1)

 

Includes amortization of deferred financing costs and debt discount and other assets.

(2)

 

Includes accounts receivable and other receivables, contract receivables, prepaid expenses and other current assets, accrued contract payables, accounts payable and accrued expenses, accrued transportation costs and other long-term liabilities.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

Three months ended June 30, 2023

 

NEMT

 

Personal Care

 

RPM

 

Corporate and Other

 

Total

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

496,975

 

 

$

180,325

 

 

$

19,211

 

 

$

2,596

 

 

$

699,107

 

Grant income

 

 

 

 

2,634

 

 

 

 

 

 

 

 

 

2,634

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Service expense

 

441,897

 

 

 

138,468

 

 

 

6,705

 

 

 

2,185

 

 

 

589,255

 

General and administrative expense

 

28,337

 

 

 

20,565

 

 

 

5,327

 

 

 

25,011

 

 

 

79,240

 

Depreciation and amortization

 

6,739

 

 

 

12,872

 

 

 

6,059

 

 

 

239

 

 

 

25,909

 

Impairment of goodwill

 

 

 

 

137,331

 

 

 

45,769

 

 

 

 

 

 

183,100

 

Total operating expenses

 

476,973

 

 

 

309,236

 

 

 

63,860

 

 

 

27,435

 

 

 

877,504

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

20,002

 

 

 

(126,277

)

 

 

(44,649

)

 

 

(24,839

)

 

 

(175,763

)

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

16,967

 

 

 

16,967

 

Income (loss) before income taxes and equity method investment

 

20,002

 

 

 

(126,277

)

 

 

(44,649

)

 

 

(41,806

)

 

 

(192,730

)

Income tax (provision) benefit

 

(5,402

)

 

 

(3,095

)

 

 

(316

)

 

 

9,643

 

 

 

830

 

Equity in net income of investee, net of tax

 

189

 

 

 

 

 

 

 

 

 

767

 

 

 

956

 

Net income (loss)

 

14,789

 

 

 

(129,372

)

 

 

(44,965

)

 

 

(31,396

)

 

 

(190,944

)

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

16,967

 

 

 

16,967

 

Income tax provision (benefit)

 

5,402

 

 

 

3,095

 

 

 

316

 

 

 

(9,643

)

 

 

(830

)

Depreciation and amortization

 

6,739

 

 

 

12,872

 

 

 

6,059

 

 

 

239

 

 

 

25,909

 

EBITDA

 

26,930

 

 

 

(113,405

)

 

 

(38,590

)

 

 

(23,833

)

 

 

(148,898

)

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs(1)

 

2,055

 

 

 

 

 

 

 

 

 

8,055

 

 

 

10,110

 

Transaction and integration costs

 

 

 

 

173

 

 

 

16

 

 

 

665

 

 

 

854

 

Settlement related costs

 

 

 

 

 

 

 

 

 

 

7,209

 

 

 

7,209

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

947

 

 

 

947

 

Impairment of goodwill

 

 

 

 

137,331

 

 

 

45,769

 

 

 

 

 

 

183,100

 

Equity in net income of investee, net of tax

 

(189

)

 

 

 

 

 

 

 

 

(767

)

 

 

(956

)

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

28,796

 

 

$

24,099

 

 

$

7,195

 

 

$

(7,724

)

 

$

52,366

 

(1)

Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

 

 

Three months ended June 30, 2022

 

 

NEMT

 

Personal Care

 

RPM

 

Corporate and Other

 

Total

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

448,733

 

 

$

162,737

 

 

$

16,745

 

 

$

 

 

$

628,215

 

Grant income

 

 

 

 

3,330

 

 

 

 

 

 

 

 

 

3,330

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Service expense

 

373,724

 

 

 

124,445

 

 

 

6,061

 

 

 

 

 

 

504,230

 

General and administrative expense

 

33,588

 

 

 

23,346

 

 

 

6,742

 

 

 

15,735

 

 

 

79,411

 

Depreciation and amortization

 

7,392

 

 

 

12,552

 

 

 

4,606

 

 

 

208

 

 

 

24,758

 

Total operating expenses

 

414,704

 

 

 

160,343

 

 

 

17,409

 

 

 

15,943

 

 

 

608,399

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

34,029

 

 

 

5,724

 

 

 

(664

)

 

 

(15,943

)

 

 

23,146

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

15,472

 

 

 

15,472

 

Income (loss) before income taxes and equity method investment

 

34,029

 

 

 

5,724

 

 

 

(664

)

 

 

(31,415

)

 

 

7,674

 

Income tax (provision) benefit

 

(9,563

)

 

 

(1,601

)

 

 

189

 

 

 

8,684

 

 

 

(2,291

)

Equity in net loss of investee, net of tax

 

 

 

 

 

 

 

 

 

 

(2,055

)

 

 

(2,055

)

Net income (loss)

 

24,466

 

 

 

4,123

 

 

 

(475

)

 

 

(24,786

)

 

 

3,328

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

15,472

 

 

 

15,472

 

Income tax provision (benefit)

 

9,563

 

 

 

1,601

 

 

 

(189

)

 

 

(8,684

)

 

 

2,291

 

Depreciation and amortization

 

7,392

 

 

 

12,552

 

 

 

4,606

 

 

 

208

 

 

 

24,758

 

EBITDA

 

41,421

 

 

 

18,276

 

 

 

3,942

 

 

 

(17,790

)

 

 

45,849

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs(1)

 

4,852

 

 

 

 

 

 

 

 

 

354

 

 

 

5,206

 

Transaction and integration costs(2)

 

 

 

 

2,830

 

 

 

1,635

 

 

 

3,237

 

 

 

7,702

 

Cash settled equity

 

 

 

 

 

 

 

 

 

 

20

 

 

 

20

 

Stock-based compensation

 

 

 

 

173

 

 

 

57

 

 

 

2,440

 

 

 

2,670

 

COVID-19 related costs, net of grant income

 

34

 

 

 

(3,378

)

 

 

 

 

 

 

 

 

(3,344

)

Equity in net loss of investee, net of tax

 

 

 

 

 

 

 

 

 

 

2,055

 

 

 

2,055

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

46,307

 

 

$

17,901

 

 

$

5,634

 

 

$

(9,684

)

 

$

60,158

 

(1)

Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

(2)

Transaction and integration costs consist of fees incurred related to Sarbanes-Oxley Act of 2002 implementation and business integration efforts.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

 

 

Six months ended June 30, 2023

 

 

NEMT

 

Personal Care

 

RPM

 

Corporate and Other

 

Total

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

966,438

 

 

$

354,456

 

 

$

37,923

 

 

$

2,596

 

 

$

1,361,413

 

Grant income

 

 

 

 

4,098

 

 

 

 

 

 

 

 

 

4,098

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Service expense

 

849,583

 

 

 

274,558

 

 

 

13,195

 

 

 

2,185

 

 

 

1,139,521

 

General and administrative expense

 

62,212

 

 

 

43,228

 

 

 

11,096

 

 

 

42,417

 

 

 

158,953

 

Depreciation and amortization

 

13,505

 

 

 

25,740

 

 

 

11,913

 

 

 

444

 

 

 

51,602

 

Impairment of goodwill

 

 

 

 

137,331

 

 

 

45,769

 

 

 

 

 

 

183,100

 

Total operating expenses

 

925,300

 

 

 

480,857

 

 

 

81,973

 

 

 

45,046

 

 

 

1,533,176

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

41,138

 

 

 

(122,303

)

 

 

(44,050

)

 

 

(42,450

)

 

 

(167,665

)

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

32,925

 

 

 

32,925

 

Income (loss) before income taxes and equity method investment

 

41,138

 

 

 

(122,303

)

 

 

(44,050

)

 

 

(75,375

)

 

 

(200,590

)

Income tax (provision) benefit

 

(11,020

)

 

 

(4,244

)

 

 

(486

)

 

 

18,453

 

 

 

2,703

 

Equity in net income of investee, net of tax

 

842

 

 

 

 

 

 

 

 

 

2,139

 

 

 

2,981

 

Net income (loss)

 

30,960

 

 

 

(126,547

)

 

 

(44,536

)

 

 

(54,783

)

 

 

(194,906

)

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

32,925

 

 

 

32,925

 

Income tax provision (benefit)

 

11,020

 

 

 

4,244

 

 

 

486

 

 

 

(18,453

)

 

 

(2,703

)

Depreciation and amortization

 

13,505

 

 

 

25,740

 

 

 

11,913

 

 

 

444

 

 

 

51,602

 

EBITDA

 

55,485

 

 

 

(96,563

)

 

 

(32,137

)

 

 

(39,867

)

 

 

(113,082

)

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs(1)

 

9,154

 

 

 

 

 

 

 

 

 

15,401

 

 

 

24,555

 

Transaction and integration costs

 

 

 

 

450

 

 

 

48

 

 

 

1,229

 

 

 

1,727

 

Settlement related costs

 

275

 

 

 

 

 

 

 

 

 

7,209

 

 

 

7,484

 

Stock-based compensation

 

 

 

 

 

 

 

 

 

 

1,795

 

 

 

1,795

 

Impairment of goodwill

 

 

 

 

137,331

 

 

 

45,769

 

 

 

 

 

 

183,100

 

Equity in net income of investee, net of tax

 

(842

)

 

 

 

 

 

 

 

 

(2,139

)

 

 

(2,981

)

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

64,072

 

 

$

41,218

 

 

$

13,680

 

 

$

(16,372

)

 

$

102,598

 

(1)

 

Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Segment Information and Adjusted EBITDA

(in thousands)

 

 

 

 

 

Six months ended June 30, 2022

 

 

NEMT

 

Personal Care

 

RPM

 

Corporate and Other

 

Total

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

849,653

 

 

$

322,435

 

 

$

30,602

 

 

$

 

 

$

1,202,690

 

Grant income

 

 

 

 

3,798

 

 

 

 

 

 

 

 

 

3,798

 

 

 

 

 

 

 

 

 

 

 

Operating expenses:

 

 

 

 

 

 

 

 

 

Service expense

 

705,820

 

 

 

246,677

 

 

 

11,048

 

 

 

 

 

 

963,545

 

General and administrative expense

 

70,921

 

 

 

46,479

 

 

 

11,704

 

 

 

27,115

 

 

 

156,219

 

Depreciation and amortization

 

14,497

 

 

 

25,057

 

 

 

8,734

 

 

 

416

 

 

 

48,704

 

Total operating expenses

 

791,238

 

 

 

318,213

 

 

 

31,486

 

 

 

27,531

 

 

 

1,168,468

 

 

 

 

 

 

 

 

 

 

 

Operating income (loss)

 

58,415

 

 

 

8,020

 

 

 

(884

)

 

 

(27,531

)

 

 

38,020

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

30,872

 

 

 

30,872

 

Income (loss) before income taxes and equity method investment

 

58,415

 

 

 

8,020

 

 

 

(884

)

 

 

(58,403

)

 

 

7,148

 

Income tax (provision) benefit

 

(16,138

)

 

 

(2,241

)

 

 

247

 

 

 

16,202

 

 

 

(1,930

)

Equity in net loss of investee, net of tax

 

(65

)

 

 

 

 

 

 

 

 

(1,507

)

 

 

(1,572

)

Net income (loss)

 

42,212

 

 

 

5,779

 

 

 

(637

)

 

 

(43,708

)

 

 

3,646

 

 

 

 

 

 

 

 

 

 

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

30,872

 

 

 

30,872

 

Income tax provision (benefit)

 

16,138

 

 

 

2,241

 

 

 

(247

)

 

 

(16,202

)

 

 

1,930

 

Depreciation and amortization

 

14,497

 

 

 

25,057

 

 

 

8,734

 

 

 

416

 

 

 

48,704

 

EBITDA

 

72,847

 

 

 

33,077

 

 

 

7,850

 

 

 

(28,622

)

 

 

85,152

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related charges (1)

 

10,456

 

��

 

181

 

 

 

24

 

 

 

385

 

 

 

11,046

 

Transaction costs (2)

 

 

 

 

4,103

 

 

 

2,282

 

 

 

5,028

 

 

 

11,413

 

Cash settled equity

 

 

 

 

 

 

 

 

 

 

7

 

 

 

7

 

Stock-based compensation

 

 

 

 

190

 

 

 

86

 

 

 

3,860

 

 

 

4,136

 

COVID-19 related costs, net of grant income

 

156

 

 

 

(3,029

)

 

 

 

 

 

 

 

 

(2,873

)

Equity in net loss of investee, net of tax

 

65

 

 

 

 

 

 

 

 

 

1,507

 

 

 

1,572

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

83,524

 

 

$

34,522

 

 

$

10,242

 

 

$

(17,835

)

 

$

110,453

 

(1)

Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

(2)

Transaction and integration costs consist of fees incurred related to Sarbanes-Oxley Act of 2002 implementation and business integration efforts.

Modivcare Inc.

Unaudited Reconciliation of Non-GAAP Financial Measures

Adjusted Net Income and Adjusted Net Income per Common Share

(in thousands, except share and per share data)

 

 

 

 

 

 

 

Three months ended June 30,

 

Six months ended June 30,

 

 

2023

 

2022

 

2023

 

2022

 

 

 

 

 

 

 

 

Net income (loss)

$

(190,944

)

 

$

3,328

 

 

$

(194,906

)

 

$

3,646

 

 

 

 

 

 

 

 

 

Restructuring and related costs(1)

 

10,110

 

 

 

5,206

 

 

 

24,555

 

 

 

11,046

 

Transaction and integration costs(2)

 

854

 

 

 

7,702

 

 

 

1,727

 

 

 

11,413

 

Settlement related costs

 

7,209

 

 

 

 

 

 

7,484

 

 

 

 

Cash settled equity

 

 

 

 

20

 

 

 

 

 

 

7

 

Stock-based compensation

 

947

 

 

 

2,670

 

 

 

1,795

 

 

 

4,136

 

Impairment of goodwill

 

183,100

 

 

 

 

 

 

183,100

 

 

 

 

Equity in net (income) loss of investee, net of tax

 

(956

)

 

 

2,055

 

 

 

(2,981

)

 

 

1,572

 

Intangible asset amortization expense

 

19,808

 

 

 

19,752

 

 

 

39,709

 

 

 

39,251

 

COVID-19 related costs, net of grant income

 

 

 

 

(3,344

)

 

 

 

 

 

(2,873

)

Tax effected impact of adjustments

 

(9,352

)

 

 

(9,299

)

 

 

(19,506

)

 

 

(18,224

)

 

 

 

 

 

 

 

 

Adjusted net income

$

20,776

 

 

$

28,090

 

 

$

40,977

 

 

$

49,974

 

 

 

 

 

 

 

 

 

Adjusted EPS

$

1.47

 

 

$

1.99

 

 

$

2.89

 

 

$

3.54

 

 

 

 

 

 

 

 

 

Diluted weighted-average number of common shares outstanding

 

14,173,854

 

 

 

14,115,471

 

 

 

14,178,375

 

 

 

14,122,730

 

(1)

 

Restructuring and related costs include professional fees for strategic initiatives, organizational consolidation costs, severance and other professional fees.

(2)

 

Transaction and integration costs consist of fees incurred related to SOX implementation and business integration efforts.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

Six months ended

 

 

 

Three months ended

 

 

 

 

June 30, 2023

 

June 30, 2022

 

% Change

 

June 30, 2023

 

June 30, 2022

 

% Change

 

March 31, 2023

 

QoQ % Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NEMT Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

496,975

 

 

$

448,733

 

 

10.8

%

 

$

966,438

 

 

$

849,653

 

 

13.7

%

 

$

469,463

 

 

5.9

%

Purchased services expense

 

377,192

 

 

 

317,213

 

 

18.9

%

 

 

721,612

 

 

 

595,160

 

 

21.2

%

 

 

344,420

 

 

9.5

%

Payroll and other expense

 

64,705

 

 

 

56,511

 

 

14.5

%

 

 

127,971

 

 

 

110,660

 

 

15.6

%

 

 

63,266

 

 

2.3

%

Service expense

$

441,897

 

 

$

373,724

 

 

18.2

%

 

$

849,583

 

 

$

705,820

 

 

20.4

%

 

$

407,686

 

 

8.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

$

55,078

 

 

$

75,009

 

 

(26.6

)%

 

$

116,855

 

 

$

143,833

 

 

(18.8

)%

 

$

61,777

 

 

(10.8

)%

Gross margin

 

11.1

%

 

 

16.7

%

 

 

 

 

12.1

%

 

 

16.9

%

 

 

 

 

13.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G&A expense

$

28,337

 

 

$

33,588

 

 

(15.6

)%

 

$

62,212

 

 

$

70,921

 

 

(12.3

)%

 

$

33,875

 

 

(16.3

)%

G&A expense adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs

 

2,055

 

 

 

4,852

 

 

(57.6

)%

 

 

9,154

 

 

 

10,456

 

 

(12.5

)%

 

 

7,099

 

 

(71.1

)%

Settlement related costs

 

 

 

 

 

 

N/M

 

 

 

275

 

 

 

 

 

N/M

 

 

 

275

 

 

N/M

 

Adjusted G&A expense

$

26,282

 

 

$

28,736

 

 

(8.5

)%

 

$

52,783

 

 

$

60,465

 

 

(12.7

)%

 

$

26,501

 

 

(0.8

)%

Adjusted G&A expense % of revenue

 

5.3

%

 

 

6.4

%

 

 

 

 

5.5

%

 

 

7.1

%

 

 

 

 

5.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

14,789

 

 

$

24,466

 

 

(39.6

)%

 

$

30,960

 

 

$

42,212

 

 

(26.7

)%

 

$

16,171

 

 

(8.5

)%

Net income margin

 

3.0

%

 

 

5.5

%

 

 

 

 

3.2

%

 

 

5.0

%

 

 

 

 

3.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

28,796

 

 

$

46,307

 

 

(37.8

)%

 

$

64,072

 

 

$

83,524

 

 

(23.3

)%

 

$

35,276

 

 

(18.4

)%

Adjusted EBITDA margin

 

5.8

%

 

 

10.3

%

 

 

 

 

6.6

%

 

 

9.8

%

 

 

 

 

7.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total paid trips (thousands)

 

8,735

 

 

 

7,831

 

 

11.5

%

 

 

16,937

 

 

 

14,942

 

 

13.4

%

 

 

8,202

 

 

6.5

%

Average monthly members (thousands)

 

34,312

 

 

 

33,792

 

 

1.5

%

 

 

34,008

 

 

 

32,984

 

 

3.1

%

 

 

33,704

 

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue per member per month

$

4.83

 

 

$

4.43

 

 

9.0

%

 

$

4.74

 

 

$

4.29

 

 

10.5

%

 

$

4.64

 

 

4.1

%

Revenue per trip

$

56.89

 

 

$

57.30

 

 

(0.7

)%

 

$

57.06

 

 

$

56.86

 

 

0.4

%

 

$

57.24

 

 

(0.6

)%

Monthly utilization

 

8.5

%

 

 

7.7

%

 

 

 

 

8.3

%

 

 

7.6

%

 

 

 

 

8.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Purchased services per trip

$

43.18

 

 

$

40.51

 

 

6.6

%

 

$

42.61

 

 

$

39.83

 

 

7.0

%

 

$

41.99

 

 

2.8

%

Payroll and other per trip

$

7.41

 

 

$

7.22

 

 

2.6

%

 

$

7.56

 

 

$

7.41

 

 

2.0

%

 

$

7.71

 

 

(3.9

)%

Total service expense per trip

$

50.59

 

 

$

47.73

 

 

6.0

%

 

$

50.17

 

 

$

47.24

 

 

6.2

%

 

$

49.70

 

 

1.8

%

N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison, thus, the percentage has been removed.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

Six months ended

 

 

 

Three months ended

 

 

 

 

June 30, 2023

 

June 30, 2022

 

% Change

 

June 30, 2023

 

June 30, 2022

 

% Change

 

March 31, 2023

 

QoQ % Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personal Care Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

180,325

 

 

$

162,737

 

 

10.8

%

 

$

354,456

 

 

$

322,435

 

 

9.9

%

 

$

174,131

 

 

3.6

%

Service expense

 

138,468

 

 

 

124,445

 

 

11.3

%

 

 

274,558

 

 

 

246,677

 

 

11.3

%

 

 

136,090

 

 

1.7

%

Gross profit

$

41,857

 

 

$

38,292

 

 

9.3

%

 

$

79,898

 

 

$

75,758

 

 

5.5

%

 

$

38,041

 

 

10.0

%

Gross Margin

 

23.2

%

 

 

23.5

%

 

 

 

 

22.5

%

 

 

23.5

%

 

 

 

 

21.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G&A expense

$

20,565

 

 

$

23,346

 

 

(11.9

)%

 

$

43,228

 

 

$

46,479

 

 

(7.0

)%

 

$

22,663

 

 

(9.3

)%

G&A expense adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs

 

 

 

 

 

 

N/M

 

 

 

 

 

 

181

 

 

N/M

 

 

 

 

 

N/M

 

Transaction and integration costs

 

173

 

 

 

2,830

 

 

(93.9

)%

 

 

450

 

 

 

4,103

 

 

(89.0

)%

 

 

277

 

 

(37.5

)%

Stock-based compensation

 

 

 

 

173

 

 

N/M

 

 

 

 

 

 

190

 

 

N/M

 

 

 

 

 

N/M

 

Adjusted G&A expense

$

20,392

 

 

$

20,343

 

 

0.2

%

 

$

42,778

 

 

$

42,005

 

 

1.8

%

 

$

22,386

 

 

(8.9

)%

Adjusted G&A expense % of revenue

 

11.3

%

 

 

12.5

%

 

 

 

 

12.1

%

 

 

13.0

%

 

 

 

 

12.9

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

$

(129,372

)

 

$

4,123

 

 

N/M

 

 

$

(126,547

)

 

$

5,779

 

 

N/M

 

 

$

2,825

 

 

N/M

 

Net income margin

 

(71.7

)%

 

 

2.5

%

 

 

 

 

(35.7

)%

 

 

1.8

%

 

 

 

 

1.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

24,099

 

 

$

17,901

 

 

34.6

%

 

$

41,218

 

 

$

34,522

 

 

19.4

%

 

$

17,119

 

 

40.8

%

Adjusted EBITDA margin

 

13.4

%

 

 

11.0

%

 

 

 

 

11.6

%

 

 

10.7

%

 

 

 

 

9.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total hours (in thousands)

 

6,933

 

 

 

6,705

 

 

3.4

%

 

 

13,757

 

 

 

13,240

 

 

3.9

%

 

 

6,824

 

 

1.6

%

Revenue per hour

$

26.01

 

 

$

24.27

 

 

7.2

%

 

$

25.77

 

 

$

24.35

 

 

5.8

%

 

$

25.52

 

 

1.9

%

Service expense per hour

$

19.97

 

 

$

18.56

 

 

7.6

%

 

$

19.96

 

 

$

18.63

 

 

7.1

%

 

$

19.94

 

 

0.2

%

N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison, thus, the percentage has been removed.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands, except for statistical data)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

Six months ended

 

 

 

Three months ended

 

 

 

 

June 30, 2023

 

June 30, 2022

 

% Change

 

June 30, 2023

 

June 30, 2022

 

% Change

 

March 31, 2023

 

QoQ % Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

RPM Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Service revenue, net

$

19,211

 

 

$

16,745

 

 

14.7

%

 

$

37,923

 

 

$

30,602

 

 

23.9

%

 

$

18,712

 

 

2.7

%

Service expense

 

6,705

 

 

 

6,061

 

 

10.6

%

 

 

13,195

 

 

 

11,048

 

 

19.4

%

 

 

6,490

 

 

3.3

%

Gross profit

$

12,506

 

 

$

10,684

 

 

17.1

%

 

$

24,728

 

 

$

19,554

 

 

26.5

%

 

$

12,222

 

 

2.3

%

Gross Margin

 

65.1

%

 

 

63.8

%

 

 

 

 

65.2

%

 

 

63.9

%

 

 

 

 

65.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G&A expense

$

5,327

 

 

$

6,742

 

 

(21.0

)%

 

$

11,096

 

 

$

11,704

 

 

(5.2

)%

 

$

5,769

 

 

(7.7

)%

G&A expense adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs

 

 

 

 

 

 

N/M

 

 

 

 

 

 

24

 

 

N/M

 

 

 

 

 

N/M

 

Transaction and integration costs

 

16

 

 

 

1,635

 

 

(99.0

)%

 

 

48

 

 

 

2,282

 

 

(97.9

)%

 

 

32

 

 

(50.0

)%

Stock-based compensation

 

 

 

 

57

 

 

N/M

 

 

 

 

 

 

86

 

 

N/M

 

 

 

 

 

N/M

 

Adjusted G&A expense

$

5,311

 

 

$

5,050

 

 

5.2

%

 

$

11,048

 

 

$

9,312

 

 

18.6

%

 

$

5,737

 

 

(7.4

)%

Adjusted G&A expense % of revenue

 

27.6

%

 

 

30.2

%

 

 

 

 

29.1

%

 

 

30.4

%

 

 

 

 

30.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

$

(44,965

)

 

$

(475

)

 

N/M

 

 

$

(44,536

)

 

$

(637

)

 

N/M

 

 

$

429

 

 

N/M

 

Net income (loss) margin

 

(234.1

)%

 

 

(2.8

)%

 

 

 

 

(117.4

)%

 

 

(2.1

)%

 

 

 

 

2.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA

$

7,195

 

 

$

5,634

 

 

27.7

%

 

$

13,680

 

 

$

10,242

 

 

33.6

%

 

$

6,485

 

 

10.9

%

Adjusted EBITDA margin

 

37.5

%

 

 

33.6

%

 

 

 

 

36.1

%

 

 

33.5

%

 

 

 

 

34.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Average monthly members (in thousands)

 

240

 

 

 

203

 

 

18.2

%

 

 

237

 

 

 

186

 

 

27.4

%

 

 

235

 

 

2.1

%

Revenue per member per month

$

26.68

 

 

$

27.50

 

 

(3.0

)%

 

$

26.67

 

 

$

27.42

 

 

(2.7

)%

 

$

26.54

 

 

0.5

%

Service expense per member per month

$

9.31

 

 

$

9.95

 

 

(6.4

)%

 

$

9.28

 

 

$

9.90

 

 

(6.3

)%

 

$

9.21

 

 

1.1

%

N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison, thus, the percentage has been removed.

Modivcare Inc.

Unaudited Key Statistical and Financial Data

(in thousands)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended

 

 

 

Six months ended

 

 

 

Three months ended

 

 

 

 

June 30, 2023

 

June 30, 2022

 

% Change

 

June 30, 2023

 

June 30, 2022

 

% Change

 

March 31, 2023

 

QoQ % Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate and Other Segment

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G&A expense

$

25,011

 

 

$

15,735

 

 

59.0

%

 

$

42,417

 

 

$

27,115

 

 

56.4

%

 

$

17,406

 

 

43.7

%

G&A expense adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs

 

8,055

 

 

 

354

 

 

N/M

 

 

 

15,401

 

 

 

385

 

 

N/M

 

 

 

7,346

 

 

9.7

%

Transaction and integration costs

 

665

 

 

 

3,237

 

 

(79.5

)%

 

 

1,229

 

 

 

5,028

 

 

(75.6

)%

 

 

564

 

 

17.9

%

Settlement related costs

 

7,209

 

 

 

 

 

N/M

 

 

 

7,209

 

 

 

 

 

N/M

 

 

 

 

 

N/M

 

Cash settled equity

 

 

 

 

20

 

 

N/M

 

 

 

 

 

 

7

 

 

N/M

 

 

 

 

 

N/M

 

Stock-based compensation

 

947

 

 

 

2,440

 

 

(61.2

)%

 

 

1,795

 

 

 

3,860

 

 

(53.5

)%

 

 

848

 

 

11.7

%

Adjusted G&A expense

$

8,135

 

 

$

9,684

 

 

(16.0

)%

 

$

16,783

 

 

$

17,835

 

 

(5.9

)%

 

$

8,648

 

 

(5.9

)%

Adjusted G&A expense % of consolidated revenue

 

1.2

%

 

 

1.5

%

 

 

 

 

1.2

%

 

 

1.5

%

 

 

 

 

1.3

%

 

 

 

Three months ended

 

 

 

Six months ended

 

 

 

Three months ended

 

 

 

June 30, 2023

 

June 30, 2022

 

% Change

 

June 30, 2023

 

June 30, 2022

 

% Change

 

March 31, 2023

 

QoQ % Change

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated Modivcare Inc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G&A expense

$

79,240

 

 

$

79,411

 

 

(0.2

)%

 

$

158,953

 

 

$

156,219

 

 

1.8

%

 

$

79,713

 

 

(0.6

)%

G&A expense adjustments

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Restructuring and related costs

 

10,110

 

 

 

5,206

 

 

94.2

%

 

 

24,555

 

 

 

11,046

 

 

N/M

 

 

 

14,445

 

 

(30.0

)%

Transaction and integration costs

 

854

 

 

 

7,702

 

 

(88.9

)%

 

 

1,727

 

 

 

11,413

 

 

(84.9

)%

 

 

873

 

 

(2.2

)%

Settlement related costs

 

7,209

 

 

 

 

 

N/M

 

 

 

7,484

 

 

 

 

 

N/M

 

 

 

275

 

 

N/M

 

Cash settled equity

 

 

 

 

20

 

 

N/M

 

 

 

 

 

 

7

 

 

N/M

 

 

 

 

 

N/M

 

Stock-based compensation

 

947

 

 

 

2,670

 

 

(64.5

)%

 

 

1,795

 

 

 

4,136

 

 

(56.6

)%

 

 

848

 

 

11.7

%

Adjusted G&A expense

$

60,120

 

 

$

63,813

 

 

(5.8

)%

 

$

123,392

 

 

$

129,617

 

 

(4.8

)%

 

$

63,272

 

 

(5.0

)%

Adjusted G&A expense % of revenue

 

8.6

%

 

 

10.2

%

 

 

 

 

9.1

%

 

 

10.8

%

 

 

 

 

9.6

%

 

 

N/M - Not Meaningful. Certain figures in the tables above do not provide meaningful percentage comparison, thus, the percentage has been removed.

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Livermore.com & California Media Partners, LLC. All rights reserved.